Detalhe da pesquisa
1.
Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective study.
BMC Nephrol
; 25(1): 124, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589827